The relationship between serum galectin-3 level and echocardiographic findings in patients with polycystic ovary syndrome
Galectin-3 levels were significantly associated with markers of subclinical atherosclerosis and early cardiac dysfunction in patients with PCOS. Galectin-3 demonstrated potential utility as a biomarker for the early identification of subclinical atherosclerosis and heart failure risk in this population. Notably, this study is the first to evaluate the association of galectin-3 with both A-IMT and GLS in patients with PCOS, providing novel insights into their cardiovascular risk profile.
Authors
- Begüm Şeyda Avcı (ORCID: https://orcid.org/0000-0001-6149-9341)
- Çiğdem Erhan (ORCID: https://orcid.org/0009-0003-4736-5699)
- Erdinç Gülümsek (ORCID: https://orcid.org/0000-0003-0026-2396)
- Dilan Damla Öztürk (ORCID: https://orcid.org/0000-0001-7418-5851)
- İbrahim Erdem (ORCID: https://orcid.org/0000-0003-4062-7900)
- Hüseyin Ali Öztürk (ORCID: https://orcid.org/0000-0001-5713-004X)
- Hilmi Erdem Sumbul
- Merve Saracoglu Sumbul
- Fatih Necip Arici
Institutions
- Sağlık Bilimleri Üniversitesi (TR)
Publication Details
- Journal
- BMC Women s Health
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1186/s12905-026-04309-1
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.00